• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环集落刺激因子-1与乳腺癌风险

Circulating colony stimulating factor-1 and breast cancer risk.

作者信息

Tamimi Rulla M, Brugge Joan S, Freedman Matthew L, Miron Alexander, Iglehart J Dirk, Colditz Graham A, Hankinson Susan E

机构信息

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

出版信息

Cancer Res. 2008 Jan 1;68(1):18-21. doi: 10.1158/0008-5472.CAN-07-3234.

DOI:10.1158/0008-5472.CAN-07-3234
PMID:18172291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2821592/
Abstract

Colony stimulating factor-1 (CSF1) and its receptor (CSF1-R) are important in mammary gland development and have been implicated in breast carcinogenesis. In a nested case-control study in the Nurses' Heath Study of 726 breast cancer cases diagnosed between June 1, 1992, and June 1, 1998, and 734 matched controls, we prospectively evaluated whether circulating levels of CSF1 (assessed in 1989-1990) are associated with breast cancer risk. The association varied by menopausal status (P(heterogeneity) = 0.009). CSF1 levels in the highest quartile (versus lowest) were associated with an 85% reduced risk of premenopausal breast cancer [relative risk (RR), 0.15; 95% confidence interval (95% CI), 0.03-0.85; P(trend) = 0.02]. In contrast, CSF1 levels in the highest quartile conferred a 33% increased risk of postmenopausal breast cancer (RR, 1.33; 95% CI, 0.96-1.86; P(trend) = 0.11), with greatest risk for invasive (RR, 1.45; 95% CI, 1.02-2.07; P(trend) = 0.06) and ER+/PR+ tumors (RR, 1.72; 95% CI, 1.11-2.66; P(trend) = 0.04). Thus, the association of circulating CSF1 levels and breast cancer varies by menopausal status.

摘要

集落刺激因子-1(CSF1)及其受体(CSF1-R)在乳腺发育中起重要作用,并与乳腺癌发生有关。在护士健康研究的一项巢式病例对照研究中,对1992年6月1日至1998年6月1日期间诊断的726例乳腺癌病例和734例匹配对照进行研究,我们前瞻性评估了1989 - 1990年测定的循环CSF1水平是否与乳腺癌风险相关。这种关联因绝经状态而异(P(异质性)=0.009)。最高四分位数(与最低四分位数相比)的CSF1水平与绝经前乳腺癌风险降低85%相关[相对风险(RR),0.15;95%置信区间(95%CI),0.03 - 0.85;P(趋势)=0.02]。相反,最高四分位数的CSF1水平使绝经后乳腺癌风险增加33%(RR,1.33;95%CI,0.96 - 1.86;P(趋势)=0.11),侵袭性肿瘤(RR,1.45;95%CI,1.02 - 2.07;P(趋势)=0.06)和ER+/PR+肿瘤(RR,1.72;95%CI,1.11 - 2.66;P(趋势)=0.04)的风险最高。因此,循环CSF1水平与乳腺癌的关联因绝经状态而异。

相似文献

1
Circulating colony stimulating factor-1 and breast cancer risk.循环集落刺激因子-1与乳腺癌风险
Cancer Res. 2008 Jan 1;68(1):18-21. doi: 10.1158/0008-5472.CAN-07-3234.
2
Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer.血清 CSF1 浓度升高可预测早期乳腺癌女性的总体生存不良。
Endocr Relat Cancer. 2013 Oct 14;20(6):777-83. doi: 10.1530/ERC-13-0198. Print 2013 Dec.
3
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.绝经前女性体内内源性甾体激素浓度与患乳腺癌风险
J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15. doi: 10.1093/jnci/djj376.
4
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.一项关于血浆催乳素浓度与绝经前和绝经后乳腺癌风险的前瞻性研究。
J Clin Oncol. 2007 Apr 20;25(12):1482-8. doi: 10.1200/JCO.2006.07.6356. Epub 2007 Mar 19.
5
Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.绝经前内源性甾体激素与乳腺癌风险:来自护士健康研究II的结果。
Breast Cancer Res. 2013 Mar 6;15(2):R19. doi: 10.1186/bcr3394.
6
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.绝经后女性的内源性激素水平、乳腺钼靶密度及后续患乳腺癌的风险。
J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. doi: 10.1093/jnci/djm062. Epub 2007 Jul 24.
7
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.绝经后女性体内内源性雌激素、雄激素和孕激素浓度与乳腺癌风险
J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65. doi: 10.1093/jnci/djh336.
8
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.绝经后血浆性激素水平与 20 多年随访期间的乳腺癌风险。
Breast Cancer Res Treat. 2013 Feb;137(3):883-92. doi: 10.1007/s10549-012-2391-z. Epub 2013 Jan 3.
9
Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.绝经后女性循环中2-羟基雌酮和16α-羟基雌酮水平与乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2029-35. doi: 10.1158/1055-9965.EPI-08-0262.
10
Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.胰岛素样生长因子I(IGF-I)、IGF结合蛋白与乳腺癌
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

引用本文的文献

1
The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy.巨噬细胞在各类肿瘤中的作用及其作为抗肿瘤治疗靶点的可能性。
Cancers (Basel). 2025 Jan 21;17(3):342. doi: 10.3390/cancers17030342.
2
Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect.CSF1R 第 550 位色氨酸在枯否素和 CSF1R 抑制剂结合及配体诱导的结构效应中的作用。
Sci Rep. 2024 May 31;14(1):12531. doi: 10.1038/s41598-024-63505-x.
3
Challenges and prospects of CSF1R targeting for advanced malignancies.针对晚期恶性肿瘤的CSF1R靶向治疗的挑战与前景
Am J Cancer Res. 2023 Jul 15;13(7):3257-3265. eCollection 2023.
4
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.乳腺肿瘤微环境中的炎症细胞因子串扰。
Int J Mol Sci. 2023 Feb 16;24(4):4002. doi: 10.3390/ijms24044002.
5
The diagnostic accuracy of macrophage colony-stimulating factor for cervical cancer: A systematic review and meta-analysis.巨噬细胞集落刺激因子诊断宫颈癌的准确性:系统评价和荟萃分析。
Medicine (Baltimore). 2022 Jul 15;101(28):e29538. doi: 10.1097/MD.0000000000029538.
6
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.早期乳腺癌患者的系统性免疫失调与可溶性共抑制和共刺激免疫检查点分子的血浆水平降低有关。
Front Immunol. 2022 May 23;13:823842. doi: 10.3389/fimmu.2022.823842. eCollection 2022.
7
Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.肿瘤相关巨噬细胞作为乳腺肿瘤生长的多面调节因子
Int J Mol Sci. 2021 Jun 18;22(12):6526. doi: 10.3390/ijms22126526.
8
Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention.通过临床外显子组测序在一名患有VACTERL综合征的婴儿中发现基因型变异:对个性化风险评估和疾病预防的支持
Pediatr Rep. 2021 Jan 5;13(1):45-56. doi: 10.3390/pediatric13010006.
9
Role of Tumor-Associated Myeloid Cells in Breast Cancer.肿瘤相关髓系细胞在乳腺癌中的作用。
Cells. 2020 Jul 27;9(8):1785. doi: 10.3390/cells9081785.
10
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.一项关于集落刺激因子1受体(CSF-1R)抑制剂培西达替尼(PLX3397)与紫杉醇联合用于晚期实体瘤患者的Ib期研究。
Ther Adv Med Oncol. 2019 Jun 21;11:1758835919854238. doi: 10.1177/1758835919854238. eCollection 2019.

本文引用的文献

1
The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.M-CSF在良性乳腺肿瘤和乳腺癌患者中的预处理血浆水平及诊断效用。
Clin Chim Acta. 2006 Sep;371(1-2):112-6. doi: 10.1016/j.cca.2006.02.033. Epub 2006 Apr 21.
2
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.集落刺激因子-1抗体可逆转人MCF-7乳腺癌异种移植瘤的化疗耐药性。
Cancer Res. 2006 Apr 15;66(8):4349-56. doi: 10.1158/0008-5472.CAN-05-3523.
3
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.通过反义寡核苷酸和小干扰RNA阻断集落刺激因子-1可抑制人乳腺肿瘤异种移植瘤在小鼠体内的生长。
Cancer Res. 2004 Aug 1;64(15):5378-84. doi: 10.1158/0008-5472.CAN-04-0961.
4
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture.自分泌集落刺激因子1受体(CSF-1R)激活促进Src依赖的乳腺上皮结构破坏。
J Cell Biol. 2004 Apr 26;165(2):263-73. doi: 10.1083/jcb.200309102.
5
The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update.集落刺激因子-1在乳腺正常生理学及乳腺癌中的作用:最新进展
Exp Biol Med (Maywood). 2004 Jan;229(1):1-11. doi: 10.1177/153537020422900101.
6
Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis.用集落刺激因子1(CSF-1)转基因拯救集落刺激因子1基因敲除小鼠(Csf1(op)/Csf1(op))的表型并鉴定局部CSF-1合成位点。
Blood. 2001 Jul 1;98(1):74-84. doi: 10.1182/blood.v98.1.74.
7
CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.集落刺激因子-1激活丝裂原活化蛋白激酶依赖且p53非依赖的信号通路,以诱导激素依赖型人乳腺癌细胞的生长停滞。
Oncogene. 1999 Dec 9;18(52):7477-94. doi: 10.1038/sj.onc.1203123.
8
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.绝经后女性血浆性甾体激素水平与乳腺癌风险
J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9. doi: 10.1093/jnci/90.17.1292.
9
Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells.Ets-2反式显性突变体消除了BT20乳腺癌细胞的非锚定依赖性生长和巨噬细胞集落刺激因子刺激的侵袭。
Cancer Res. 1998 Mar 1;58(5):1027-33.
10
Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.巨噬细胞集落刺激因子1受体不同自磷酸化位点对侵袭和不依赖贴壁生长的独立调节
Cancer Res. 1996 Dec 15;56(24):5704-12.